Cyr61 inhibitors target and modulate the activity of the Cyr61 protein. Cyr61, also known as CCN1, belongs to the CCN (Cyr61/CTGF/Nov) family of matricellular proteins, which are secreted into the extracellular matrix and play multifaceted roles in cellular functions and tissue remodeling. Cyr61 is involved in diverse cellular processes, and its functions are mediated through interactions with various cell surface receptors, such as integrins and heparan sulfate proteoglycans. Upon binding to these receptors, Cyr61 triggers intracellular signaling pathways that modulate cellular responses to extracellular cues. It is an essential regulator of processes like cell adhesion, migration, proliferation, and survival. Additionally, Cyr61 plays a pivotal role in angiogenesis, the formation of new blood vessels from pre-existing ones, which is crucial for tissue growth and repair. Cyr61 inhibitors are specifically designed to disrupt the interactions between Cyr61 and its cellular receptors, disrupting the transmission of intracellular signals that would typically be initiated by Cyr61 binding. By doing so, these inhibitors can interfere with downstream gene expression and cellular responses that are influenced by Cyr61's activities.
The chemical structures of Cyr61 inhibitors may vary significantly, as researchers continually refine and optimize these compounds to enhance their selectivity and efficacy in modulating Cyr61's functions. The exact mechanisms by which Cyr61 inhibitors interact with Cyr61 and inhibit its activity can also differ based on their specific molecular properties. The targeted modulation of Cyr61 activity by these inhibitors has proven to be an invaluable tool in basic research. By using Cyr61 inhibitors, scientists can delve into the intricate regulatory networks that govern various cellular processes, shedding light on the significance of Cyr61 in normal physiological functions. Cyr61 inhibitors represent a specialized chemical class of compounds designed to selectively target Cyr61 and disrupt its interactions with cellular receptors. Through this targeted modulation, these inhibitors offer valuable tools for researchers to investigate the multifaceted roles of Cyr61 in cellular processes, tissue homeostasis, and angiogenesis, contributing to the advancement of knowledge in various fields of cellular biology.
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
NSC 632839 hydrochloride | 157654-67-6 | sc-204138 sc-204138A | 10 mg 50 mg | ¥1343.00 ¥5246.00 | ||
抑制 COL2A1 的表达和 II 型胶原蛋白的合成,减少软骨降解和细胞外基质重塑,从而减少骨关节炎等关节疾病的发生。 | ||||||
SB-3CT | 292605-14-2 | sc-205847 sc-205847A | 1 mg 5 mg | ¥1128.00 ¥4287.00 | 15 | |
抑制 COL2A1 基因转录和 MMP-2/9 激活,减轻与骨关节炎相关的软骨降解和炎症过程。 | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | ¥1749.00 | 6 | |
减少 COL2A1 的表达和促炎细胞因子,通过其抗炎特性减轻关节炎对软骨的破坏。 | ||||||
Chondroitinase ABC from Proteus vulgaris | 9024-13-9 | sc-507341 | 2 U | ¥7333.00 | ||
裂解 aggrecan 上的糖胺聚糖链,调节 COL2A1 的周转和软骨修复过程中的基质重塑。 | ||||||
Heat Shock Protein Inhibitor I | 218924-25-5 | sc-221709 | 5 mg | ¥1072.00 | 5 | |
间接抑制 Hsp70,减少 COL2A1 的表达,可能对关节炎和其他胶原蛋白相关疾病有治疗作用。 | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | ¥2053.00 ¥7818.00 | 88 | |
阻断 Rho- 相关蛋白激酶(ROCK),可能调节 COL2A1 的合成,改善纤维化和软骨疾病。 | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | ¥2008.00 | 25 | |
抑制钙离子/钙调蛋白依赖性蛋白激酶 II(CaMKII),减少 COL2A1 的表达和钙依赖性胶原相关途径。 | ||||||
Piperine | 94-62-2 | sc-205809 sc-205809A | 5 g 25 g | ¥406.00 ¥1613.00 | 3 | |
下调 COL2A1 和炎性细胞因子,通过其抗炎特性可能缓解关节炎中的软骨退化。 |